Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
AXL overexpression
i
Other names:
AXL Receptor Tyrosine Kinase, Tyrosine Protein Kinase Receptor UFO, AXL Oncogene, AXL Transforming Sequence Gene, Tyro7
Associations
(10)
News
Trials
C3 | Sensitive
D | Sensitive
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
EGFR
Tyrosine Kinase Inhibitors
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Serine-Threonine Kinase Inhibitors
Threonine-Tyrosine Kinase Inhibitors
Chemotherapy
DNA
Cancel
Colorectal Cancer
Clear Cell Renal Cell Carcinoma
Non Small Cell Lung Cancer
Ovarian Cancer
Squamous Cell Carcinoma of Head and Neck
Melanoma
Adenoid Cystic Carcinoma
cetuximab
C3
AXL overexpression
|
Colorectal Cancer
|
cetuximab
D
AXL overexpression
|
Squamous Cell Carcinoma of Head and Neck
|
cetuximab
nivolumab
C3
AXL overexpression
|
Clear Cell Renal Cell Carcinoma
|
nivolumab
osimertinib
C3
AXL overexpression
|
Non Small Cell Lung Cancer
|
osimertinib
afatinib
D
AXL overexpression
|
Non Small Cell Lung Cancer
|
afatinib
ASP8273
D
AXL overexpression
|
Non Small Cell Lung Cancer
|
ASP8273
VS-6766 + BGB324
D
AXL overexpression
|
Ovarian Cancer
|
VS-6766 + BGB324
BGB324
D
AXL overexpression
|
Melanoma
|
BGB324
vemurafenib + BGB324
D
AXL overexpression
|
Melanoma
|
vemurafenib + BGB324
ADCT-601
D
AXL overexpression
|
Adenoid Cystic Carcinoma
|
ADCT-601
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
